Compugroup Medical SE & Co. KGaA

Compugroup Medical SE & Co. KGaA

COP · HM

28.20EUR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close28.20
Open28.15
Day Range28.15 – 28.20
52-Week Range22.87 – 30.40
Volume69
Market Cap1.40B
P/E (TTM)55.77
Forward P/E0.00
EPS0.52
Dividend Yield0.21%
Beta0.77
50-Day Avg27.72
200-Day Avg27.12

About

CompuGroup Medical SE & Co. KGaA provides e-health services in Germany, Western and Eastern Europe, North America, and internationally. It operates through Ambulatory Information Systems (AIS), Hospital Information Systems (HIS), and Pharmacy Information Systems (PCS) segments. The Ambulatory Information Systems segment develops and sells practice management software for registered physicians, medical care centers, and physician networks. This segment also offers solutions that cover all essential clinical, administrative, and billing functions, as well as internet and intranet solutions for the secure exchange of doctor and patient information; and data-driven products, software interfaces for information exchange, medical decision support tools, pharmaceutical and therapy databases, solutions for the insurance industry, and digital applications and mobile apps, as well as provides facilities for medical care centers and practice associations. Its Hospital Information Systems segment offers clinical and administrative solutions for the inpatient healthcare sector, including the facilitation of patient administration, resource and personnel management, medical-care documentation, billing, and financial and medical controlling; and clinical applications to support specialist departments, medical laboratories and radiology networks. This segment serves acute care hospitals, rehabilitation centers, welfare institutions, hospital networks, medical laboratories, and radiologists. The Pharmacy Information Systems segment provides administrative and billing-related software applications for pharmacies, which supports aspects of the supply chain for medication from procuring and shipping the medication, managing and controlling inventory, through to planning, and performing and monitoring retail activities. CompuGroup Medical SE & Co. KGaA was founded in 1987 and is headquartered in Koblenz, Germany.

Company Details

  • CEODr. Daniel Gotthardt Ph.D.
  • Employees8.70K
  • HeadquartersMaria Trost 21, Koblenz, Germany, 56070, Germany
  • Websitehttps://www.cgm.com

Leadership

  • Dr. Daniel Gotthardt Ph.D.MD, CEO & Head of Ambulatory Information Systems DACH · b. 1973
  • Ms. Daniela HommelMD & CFO · b. 1975
  • Mr. Hannes ReichlChief Operating Officer · b. 1976
  • Mr. Frank GotthardtChairman of Management Board · b. 1950
  • Dr. Klaus Esser Ph.D.Vice Chairman of Management Board
  • Mr. Daniel Pindur Ph.D.Member of Management Board · b. 1978
  • Mr. Can ToygarMember of Management Board
  • Mr. Christoph RotteleMember of Management Board · b. 1970
  • Ms. Claudia ThoméCorporate Vice President of Investor Relations · b. 1970
  • Mr. Helge WeißSenior Vice President of Connectivity

Financials

Income Statement

Currency: EUR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Revenue560.20M582.38M717.02M745.81M837.26M1.03B1.13B1.19B1.15B
Growth (%)-+3.96%+23.12%+4.01%+12.26%+22.46%+10.18%+5.13%-2.84%
Cost of Revenue94.04M90.34M132.92M114.39M124.31M154.13M171.58M182.61M188.84M
Gross Profit466.15M492.03M584.11M631.42M712.95M871.19M958.16M1.01B965.14M
Gross Margin83.21%84.49%81.46%84.66%85.15%84.97%84.81%84.62%83.64%
Operating Expense391.00M412.19M451.21M524.31M587.59M763.29M850.70M882.12M859.40M
Operating Income75.15M79.84M132.90M107.11M125.37M107.90M107.46M122.93M105.74M
Operating Margin13.41%13.71%18.53%14.36%14.97%10.52%9.51%10.35%9.16%
EBITDA-111.43M179.76M174.92M191.56M213.99M228.25M--
EBITDA Margin-19.13%25.07%23.45%22.88%20.87%20.20%--
Net Income44.53M31.25M92.34M65.82M73.19M68.97M73.41M45.92M34.60M
Net Income Margin7.95%5.37%12.88%8.83%8.74%6.73%6.50%3.87%3.00%
Interest Expense006.41M4.32M6.36M5.40M9.12M24.34M33.36M
Interest Expense % of Total Revenue0.00%0.00%0.89%0.58%0.76%0.53%0.81%2.05%2.89%

Balance Sheet

Currency: EUR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Assets807.90M825.01M848.31M1.07B1.57B1.79B1.94B1.90B1.97B
Total Liabilities589.25M588.95M575.31M805.95M926.84M1.18B1.27B1.23B1.32B
Total Equity217.83M234.17M270.89M259.11M638.67M612.07M672.42M667.68M647.91M
Cash25.35M26.38M19.63M43.78M74.61M107.29M90.46M64.41M107.18M
Net Debt-327.77M289.39M423.89M435.37M576.80M642.66M646.10M718.36M

Cash Flow

Currency: EUR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Operating Cash Flow67.61M85.82M136.35M110.50M149.93M165.27M145.03M179.53M128.88M
Capital Expenditure42.37M47.05M40.35M43.74M57.76M77.50M81.04M75.41M63.23M
Free Cash Flow-38.77M96.00M66.75M92.17M87.78M63.99M104.11M65.66M
Dividends Paid17.40M17.40M17.40M24.41M24.21M26.37M26.12M26.12M51.73M
FCF to OCF-45.18%70.40%60.41%61.48%53.11%44.12%57.99%50.94%
Dividend Paid to FCF-44.88%18.13%36.57%26.26%30.04%40.81%25.09%78.80%

Earnings

Report DateAug 10, 2023Jul 31, 2025
EPS Estimate0.570.36
EPS Actual0.620.30
Surprise8.77%-16.67%
TimingPre-marketAfter-hours

Key Statistics & Ratios

Market Cap1.40B
Enterprise Value2.22B
Trailing P/E55.77
Forward P/E0.00
PEG Ratio0.00
Price / Sales1.12
Price / Book1.79
EPS0.52
Book Value12.41
Revenue (TTM)1.25B
Gross Profit (TTM)422.33M
EBITDA133.26M
Profit Margin2.27%
Operating Margin7.38%
Return on Equity4.45%
Return on Assets2.84%
Shares Outstanding51.73M
Shares Float8.24M
Beta0.77
Dividend Yield0.21%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20261×
0.50Apr 20, 2026
20251×
0.05Aug 4, 2025
20241×
1.00May 23, 2024
20231×
0.50May 18, 2023
20201×
0.50May 14, 2020
20191×
0.50May 16, 2019
20181×
0.35May 16, 2018
20171×
0.35May 11, 2017
20161×
0.35May 19, 2016
20151×
0.35May 21, 2015
20141×
0.35May 15, 2014
20131×
0.35May 16, 2013
20121×
0.25May 10, 2012
20111×
0.25May 12, 2011
20101×
0.25May 20, 2010

Stock Splits

  • Oct 23, 200625:1